
Commentary|Articles|October 17, 2025
AJMC® in the Press, October 17, 2025
Author(s)Julia Bonavitacola
Fact checked by: Christina Mattina
Listen
0:00 / 0:00
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Advertisement
An item from
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
2
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
3
Fixed-Duration Epcoritamab Plus Chemotherapy Yields Response, Remissions in DLBCL
4
Once-Monthly Maridebart Cafraglutide Shows Up to 16% Weight Loss
5













































